| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| AFX-5931 | AFX-5931 | Phase 2 Clinical | Eczema | Details | |
| MW-151 | MW01-9-034WH; MW-151; MW01-2-151SRM | Phase 1 Clinical | University Of Kentucky | Drug-Related Side Effects and Adverse Reactions; Poisoning; Cognition Disorders | Details |